Cargando...
Bioengineering Solutions for Manufacturing Challenges in CAR T Cells
The next generation of therapeutic products to be approved for the clinic is anticipated to be cell therapies, termed “living drugs” for their capacity to dynamically and temporally respond to changes during their production ex vivo and after their administration in vivo. Genetically engineered chim...
Guardado en:
| Publicado en: | Biotechnol J |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796845/ https://ncbi.nlm.nih.gov/pubmed/28840981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/biot.201700095 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|